Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis. A randomised trial. Weitere Informationen
Effect of preventive administration of a nonpathogenic Escherichia coli strain on the colonization of the intestine with microbial pathogens in newborn infants. Weitere Informationen
Probiotic Escherichia coli Nissle 1917 (EcN) for successful remission maintenance of ulcerative colitis in children and adolescents. An open-label pilot study. Weitere Informationen
